Japan Cell Therapy Market Size & Outlook, 2023-2030

Name: Japan Cell Therapy Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The cell therapy market in Japan is expected to reach a projected revenue of US$ 699.2 million by 2030. A compound annual growth rate of 23.2% is expected of Japan cell therapy market from 2024 to 2030.

Japan cell therapy therapy type outlook (Revenue, USD million, 2018-2030)
- Allogeneic Therapies
  - Stem Cell Therapies
    - Hematopoietic Stem Cell Therapies
    - Mesenchymal Stem Cell Therapies
  - Non-stem Cell Therapies
    - Keratinocytes & Fibroblast-based Therapies
    - Others
- Autologous Therapies
  - Stem Cell Therapies
    - BM, Blood, & Umbilical Cord-derived Stem Cells
    - Adipose Derived Cells
    - Others
  - Non-stem Cell Therapies
    - T-Cell Therapies
      - CAR T Cell Therapy
      - T Cell Receptor (TCR)-based
    - Others
Japan cell therapy therapeutic area outlook (Revenue, USD million, 2018-2030)
- Oncology
- Cardiovascular Disease (CVD)
- Musculoskeletal Disorders
- Dermatology
- Others

Japan Cell Therapy Market Size & Outlook, 2023-2030

Sign up - it's easy, and free!